Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Research Funding Resources

Research Funding Resources

Explore this section to find information on research funding opportunities from the National Institutes of Health and other sources

General Funding Resources

Grants – Office of Extramural Research

NIH medical and behavioral research grant policies, guidelines, and funding opportunities including the NIH Guide for Grants and Contracts.

NIH Research Portfolio Online Reporting Tool Expenditure & Results (RePORTER)

Use the RePORTER database to find information on all NIH-funded research activities. Some of the studies may be enrolling participants, while others involve only laboratory experiments.

Search for grant programs across the Federal government.

NIH Center for Scientific Review (CSR)

The Center for Scientific Review (CSR) is the portal for NIH grant applications and their review for scientific merit. They organize the peer review groups or study sections that evaluate the majority of the research grant applications sent to NIH. Their mission is to see that NIH grant applications receive fair, independent, expert, and timely reviews so NIH can fund the most promising research.

NIH Small Business Funding Opportunities

Resources available through the Small Business Innovation Research and the Small Business Technology Transfer programs.

Back to top

Funding Resources for Specific Diseases

Alport Syndrome Foundation

The Alport Syndrome Foundation (ASF), the Pedersen Family, and the Kidney Foundation of Canada (KFOC) have partnered to provide funding for basic science and clinical research that will enhance the understanding and treatment of Alport syndrome.

Aplastic Anemia & MDS International Foundation

The Aplastic Anemia MDS International Foundation offers 2-year research grants of $30,000 per year to advance the understanding and treatment of bone marrow failure diseases, including aplastic anemia, myelodysplastic syndromes (MDS), and paroxysmal nocturnal hemoglobinuria (PNH).The research grant program application and guidelines are available at the MDSIF Web site.

Foundation for Prader-Willi Research

The Foundation for Prader-Willi Research supports research to advance the understanding and treatment of Prader-Willi syndrome (PWS). The Foundation is particularly interested in supporting projects that will lead to new interventions to alleviate the symptoms associated with PWS.

Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension

The mission of the Gilead Sciences Research Scholars Program in Pulmonary Arterial Hypertension (PAH) is to support innovative scientific research that will advance knowledge in the field of pulmonary arterial hypertension, or PAH.

Histiocytosis Association

The Histiocytosis Association has an annual program for submitting proposals for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders.

Muscular Dystrophy Association (MDA)

MDA's research program is a dedicated partnership between scientists and concerned citizens aimed at conquering neuromuscular disease. MDA combats some 40 neuromuscular diseases through a worldwide extramural research program that includes basic, clinical, and translational research efforts as well as a clinical research training grant program.

National Ataxia Foundation (NAF)

The National Ataxia Foundation funds four types of research grants for new and innovative studies that are relevant to the cause, pathogenesis, or treatment of the hereditary or sporadic ataxias.

National Marfan Foundation

The National Marfan Foundation provides financial support for investigators studying all aspects of Marfan syndrome and related disorders. 

National MPS Society

The National MPS Society funds research that may lead to treatments for MPS diseases and solicits applications for innovative research projects that involve basic research, translational studies and clinical research.

National Organization for Rare Disorders (NORD)

NORD’s Research Grant Program provides seed grants to academic scientists for translational or clinical studies related to development of potential new diagnostics or treatments for rare disease. In at least two cases, NORD grants have resulted ultimately in FDA-approved treatments for patients.

NephCure Foundation

The NephCure Foundation is the only organization devoted exclusively to supporting research into the cause of and cure for Idiopathic Nephrotic Syndrome and primary Focal Segmental Glomerulosclerosis (FSGS). Comprised of patients, their families and friends, researchers, physicians, and other health care professionals, NephCure has a growing program of scientific support.

Neurodegeneration with Brain Iron Accumulation (NBIA) Disorders Association

The NBIA Disorders Association Research Grant Program provides one-year grants for clinical and translational research studies related to the early detection, diagnosis, or treatment of patients with NBIA.

Prader-Willi Syndrome Association

The Prader-Willi Syndrome Association (USA) is supporting projects that have the potential for immediate and high impact for the PWS community, thus will support research-based translational grants or those showing high promise for translating basic biomedical knowledge to clinical application. The goal is to fast-track better treatment for the syndrome. 

Progeria Research Foundation (PRF)

Awards of up to $50,000 per year for up to 2 years are available from PRF to support investigators for basic science research aimed at developing effective treatments and/or a cure for Hutchinson-Gilford Progeria Syndrome and its aging-related disorders. Principal investigators must hold postdoctoral positions or beyond. Awards will be granted only to applicants affiliated with institutions with 501(c)3 status or the equivalent for foreign institutions.

Pulmonary Hypertension Association (PHA)

PHA's Research Program provides grants to promising researchers seeking to better understand pulmonary hypertension. The program supports PH research projects ranging from early, exploratory and developmental work to projects that facilitate mentorship and ensure a future of innovative investigators in the field. Information about PHA's 2015 Research Portfolio, including eligibility criteria and deadlines, can be found at the link above. For additional information, please contact

United Mitochondrial Disease Foundation (UMDF)

The UMDF promotes research and education for the diagnosis, treatment, and cure of mitochondrial disorders and provides support to affected individuals and families. Through its Research Program, UMDF awards more than $1 million per year in grants to scientists conducting basic research into mitochondrial disorders as well as for clinical studies focusing on diagnosis and treatment.

Vasculitis Foundation

The purpose of the Vasculitis Foundation Research Grant Program is to provide 1- or 2-year seed grants to support pilot studies in researching the etiology; epidemiology; diagnosis; treatment; including approaches that would prevent complications; and development of coping skills for living with this disease.

The Multiple System Atrophy (MSA) Coalition

The Multiple System Atrophy Coalition requests grant applications for research relevant to the cure, cause, prevention, improved treatment, diagnosis and/or understanding of multiple system atrophy. Seed grants of up to $50,000 each are available. All applications must be submitted to the MSA Coalition via email by May 10, 2016 - 5pm US ET. Through this initiative, the Multiple System Atrophy Coalition invites grant applications from professionals committed to conducting novel, emerging, or innovative research that could lead to greater understanding of multiple system atrophy and other neurodegenerative disorders.

Back to top

NCATS-Supported Programs

Clinical and Translational Science Awards (CTSA)

The CTSA program in the NCATS Division of Clinical Innovation supports a national consortium of medical research institutions that work together to improve the way clinical and translational research is conducted nationwide to enhance its efficiency and quality.

Assay Development and Screening Technology

The Assay Development and Screening Technology (ADST) program works to optimize assays requested or submitted by the biomedical research community for high-throughput small-molecule screening. 

Bridging Interventional Development Gaps (BrIDGs)

BrIDGs makes available, on a competitive basis, certain critical resources needed for the development of new therapeutic agents.

Chemistry Technology

NIH Chemical Genomics Center's Chemistry Technology Group in the NCATS Division of Pre-Clinical Innovation aims to solve fundamental problems and insufficiencies in molecular biology and drug discovery through investments in chemistry technology projects ranging from novel library design to inventive bioanalytical techniques.

Molecular Libraries Probe Production Center

The NIH Chemical Genomics Center is one of the centers in the Molecular Libraries Probe Production Centers Network (MLPCN), which is an NIH Common Fund Initiative.

NIH Chemical Genomics Center (NCGC)

The goals of NCGC in the NCATS Division of Pre-Clinical Innovation are to translate the discoveries of the Human Genome Project into biological and disease insights and ultimately new therapeutics for human disease through small molecule assay development, high-throughput screening, cheminformatics and chemistry.


NIH established a state-of-the-art RNAi screening facility administered by the NCATS Division of Pre-Clinical Innovation that accepts proposals from any intramural researcher.

Therapeutics for Rare and Neglected Diseases (TRND)

The TRND program in the NCATS Division of Pre-Clinical Innovation aims to encourage and speed the development of new drugs for rare and neglected diseases.

Toxicology in the 21st Century (Tox21)

The Tox21 program is a federal collaboration involving the NIH, Environmental Protection Agency (EPA), and Food and Drug Administration (FDA) aimed at developing better toxicity assessment methods.

Tissue Chip for Drug Screening

The Tissue Chip for Drug Screening initiative, which marks the first interagency collaboration launched by NCATS, aims to develop 3-D human tissue chips that accurately model the structure and function of human organs, such as the lung, liver and heart.

Discovering New Therapeutic Uses for Existing Molecules

This collaborative pilot program is designed to develop partnerships between pharmaceutical companies and the biomedical research community to advance therapeutic development.

Back to top

NCATS Funding & Notices

NCATS Open Funding Opportunities

Learn more about the funding and collaboration opportunities that NCATS offers.

NCATS Small Business Funding Programs

NCATS seeks to increase small business participation in federally supported research and development as well as private-sector commercialization of technology developed with federal support.

Back to top

Locate healthcare providers and researchers who have knowledge of your condition.

Navigate the process of trying to obtain a diagnosis.